The Shadow of Bone - Metastasis & Leukemia's Pathways (welcome! Let's delve into the challenges o

[Fraser]

The ability to differentiate based on specific markers - like myelogenome abnormalities - is essential, but can be difficult to interpret with varying levels of aggressiveness. Do you think we should focus more heavily on the underlying genetic causes of leukemia, rather than just the clinical symptoms?

[Copeland]

I'm wondering if the diagnostic approach – blood tests and bone marrow biopsies – are becoming increasingly integrated in a single process - creating a comprehensive view of the patient's oncology. What is your opinion on the role of genetic testing in predicting prognosis in leukemia patients?